Skip to main content
. 2022 May 31;20(2):228–239. doi: 10.9758/cpn.2022.20.2.228

Fig. 1.

Fig. 1

Intrasignaling pathways as the mechanism of action for mood stabilizers, antipsychotics and antidepressants. AC, adenylyl cyclase; AP-1, activator protein-1; BDNF, brain-derived neurotrophic factor; CaMK, Ca2+/calmodulin-dependent kinase; cAMP, cyclic adenosine-3′,5′-monophosphate; CREB, cAMP-responsive element binding protein; DAG, diacylglycerol; GPCR, G protein-coupled receptor; GSK-3β, glycogen synthase kinase-3β; IP3, inositol 1,4,5-triphosphate; MARCKS, myristoylated alanine-rich C-kinase substrate; PI3K, phos-phoinositide 3-kinase; PLC, phospholipase C; PKA, protein kinase A; PKB, protein kinase B; PKC, protein kinase C; TrkB, tropomyosin receptor kinase B. Original illustration created with BioRender.com by MK Seo.